Dividend/Distribution - CUV
Melbourne, Australia, 26 August 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...
Read More
Insider Insights III: Willem Blijdorp - Challenges & the Future
CLINUVEL today launches the third and final part of the Insider Insights...
Read More
Insider Insights II: Willem Blijdorp - CLINUVEL’s Products, People & Social Purpose
CLINUVEL today launches the next part of the Insider Insights series, featuring...
Read More
Insider Insights: Willem Blijdorp - Chair of The CLINUVEL Group
CLINUVEL today launched the Insider Insights series, featuring Chair Willem Blijdorp on...
Read More
CLINUVEL Presentation to Jefferies Healthcare Conference
Melbourne, Australia, 04 June 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...
Read More
Wilsons Initiates Research Coverage of CLINUVEL
Melbourne, Australia, 26 April 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...
Read More
CLINUVEL Strategic Update II
Melbourne, Australia, 12 April 2021 CLINUVEL today announced its second Strategic Update,...
Read More
Media Release - CLINUVEL Expands DNA Repair Program
SCENESSE® (afamelanotide 16mg) to be evaluated in xeroderma pigmentosum variant (XP-V) CLINUVEL...
Read More
SCENESSE® To Be Evaluated in Xeroderma Pigmentosum Variant (XPV)
CLINUVEL today announced that it has reached agreement with clinical and academic...
Read More
SCENESSE® Granted Market Access In Israel
CLINUVEL today announced that SCENESSE® (afamelanotide 16mg) has been added to the...
Read More
H.C. Wainwright Bioconnect Conference 2021
12 January 2021 https://vimeo.com/clinuvel/review/499638631/b90c97ddb9 Download Presentation & Speaker Notes
Read More
Appendix 3G
Notification of issue, conversion or payment up of equity & securities. Download...
Read More
SCENESSE® DNA REPAIR STUDY IN HEALTHY VOLUNTEERS APPROVED
Melbourne, Australia, 30 November 2020 CLINUVEL PHARMACEUTICALS LTD today announced that it...
Read More
Jefferies Virtual London Healthcare Conference Presentation
20 November 2020 Download presentation & speaker’s notes
Read More
Chair's Letter To Shareholders
19 November 2020 Dear fellow shareholder, I look back at a year...
Read More